WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics ...
Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.
Credit: Tada Images/Shutterstock. Boehringer Ingelheim and Circle Pharma have entered a new research partnership and licence agreement to develop a new precision cancer treatment. The partnership aims ...
At the end of the episode, before the credits roll a pop up appears on the screen sharing a dedication to Martin Maynard. So who was Martin Maynard? Here's what you need to know about the man the ...
Under development at German family-owned pharma major Boehringer Ingelheim, survodutide is a dual glucagon/GLP-1 receptor agonist for the treatment of adults living with non-cirrhotic metabolic ...
Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...
"We are collaborating with the pharmaceutical companies that developed these, alongside the World Health Organization, to expedite the process through multilateral collaboration." The WHO said it ...
Oct 3 (Reuters) - WuXi AppTec (603259.SS), opens new tab and WuXi Biologics (2269.HK), opens new tab are planning to sell some of their operations after the Chinese biotech companies were targeted ...
IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM) (“Reneo”) today announced the results of the special meeting of its stockholders held on September ...
The Biosecure Act has made the pharmaceutical industry the latest sector subject to growing trade and national security tensions between the US and China after technology companies such as TikTok ...
Shares of Mankind Pharma continued its gaining streak for the second straight session on Thursday, after falling in the previous four sessions, as sentiments were lifted after the homegrown pharma ...